Amyloid beta (Aβ) plaques and neurofibrillary tangles (NFTs) combined with deficits in learning and memory are hallmarks of Alzheimer’s Disease (AD).
Understanding how plaques and tangles are formed and discovering effective therapeutics that prevent these neurodegenerative processes are important factors for winning the
battle against Alzheimer’s Disease.
As part of Taconic's Neuroscience Portfolio, we offer a variety of transgenic rodent models that
develop plaques and tangles and allow screening of novel drug candidates for treatments against Alzheimer’s and other neurodegenerative diseases.